Nomura Holdings, Inc. (NRSCF)
OTCMKTS
· Delayed Price · Currency is USD
6.00
0.00 (0.00%)
Jun 3, 2025, 8:00 PM EDT
Nomura Holdings Revenue
In the fiscal year ending March 31, 2025, Nomura Holdings had annual revenue of 1.89T JPY with 21.16% growth. Nomura Holdings had revenue of 452.74B in the quarter ending March 31, 2025, with 1.71% growth.
Revenue
1,892.49B JPY
Revenue Growth
+21.16%
P/S Ratio
1.47
Revenue / Employee
70.48M JPY
Employees
26,850
Market Cap
18.52B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1,892.49B | 330.49B | 21.16% |
Mar 31, 2024 | 1,562.00B | 226.42B | 16.95% |
Mar 31, 2023 | 1,335.58B | -28.31B | -2.08% |
Mar 31, 2022 | 1,363.89B | -44.98B | -3.19% |
Mar 31, 2021 | 1,408.87B | 123.04B | 9.57% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Federal National Mortgage Association | 30.44B |
Federal Home Loan Mortgage | 23.43B |
First National of Nebraska | 1.89B |
Mechanics Bank | 381.61M |
Wilson Bank Holding Company | 189.72M |
Copper Property CTL Pass Through Trust | 99.49M |
Horizon Kinetics Holding | 64.85M |
First National Bank Alaska | 199.84M |
Nomura Holdings News
- 15 days ago - Nomura maintains ‘Neutral’ on Sun Pharma, flags margin risks as investments rise in FY26 - Business Upturn
- 17 days ago - Brokerage radar: Hindalco, BEL, Dixon, Zydus, Gland Pharma in focus after Q4; target prices revised - Business Upturn
- 25 days ago - Nomura upgrades China stocks to ‘tactical overweight’ after tentative trade breakthrough - South China Morning Post
- 25 days ago - Citi, Nomura cautious on pharma after US price control move; Sun Pharma seen at risk - Business Upturn
- 4 weeks ago - Nomura pinches JPMorgan managing director - The Australian Financial Review
- 5 weeks ago - Amid tariff uncertainty markets are in the eye of the storm: Nomura - CNBC
- 5 weeks ago - Oberoi Realty share price: Nomura sees 23% upside as new project pipeline offsets Thane slowdown - Business Upturn
- 5 weeks ago - Brokerage radar: Bajaj Finance, Trent, BPCL, Ambuja Cement, Oberoi Realty in focus after earnings and estimates - Business Upturn